MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 5 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in MoonLake Immunotherapeutics as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −11 vs. Q4 2023
- Shares held
- 59.5M
- +192.3K (+0.3%) vs. Q4 2023
- Total value
- $2.99B
- −$539.2M (−15.3%) vs. Q4 2023
- New holders
- 22
- 44 more added
- Sold out
- 33
- 37 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 3,779 | $189.8K | 0.00% | −2,335−38.2% | Reduced |
| ADAR1 Capital Management, LLC | 3,000 | $150.7K | 0.04% | +3,000 | New |
| Cutler Group LP | 2,500 | $125.0K | 0.06% | +1,400+127.3% | Added |
| Belvedere Trading LLC | 2,201 | $110.6K | 0.01% | +2,201 | New |
| Virtus ETF Advisers LLC | 1,504 | $75.5K | 0.04% | −101−6.3% | Reduced |
| Quarry LP | 1,100 | $55.3K | 0.02% | +250+29.4% | Added |
| EntryPoint Capital, LLC | 862 | $43.3K | 0.04% | −860−49.9% | Reduced |
| Deutsche Bank AG | 565 | $28.4K | 0.00% | 00.0% | Unchanged |
| KBC Group NV | 565 | $28.0K | 0.00% | +565 | New |
| Tower Research Capital LLC (TRC) | 279 | $14.0K | 0.00% | +214+329.2% | Added |
| Private Trust Co NA | 122 | $6.13K | 0.00% | −16−11.6% | Reduced |
| Advisor Group Holdings, Inc. | 100 | $5.02K | 0.00% | −1,917−95.0% | Reduced |
| Wells Fargo & Company | 100 | $5.02K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5 | $251 | 0.00% | −1,443−99.7% | Reduced |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −1,039,289−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −238,231−100.0% | Sold out |
| Senator Investment Group LP | 0 | $0 | 0.00% | −155,000−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −143,479−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −128,700−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −113,757−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −47,604−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −35,179−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −28,417−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −21,336−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −20,317−100.0% | Sold out |
| Sand Grove Capital Management LLP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −18,903−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −18,728−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −18,699−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −14,425−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,227−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −9,744−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −5,398−100.0% | Sold out |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −4,455−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −3,853−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −3,505−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −3,350−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,297−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |